Pharmacotherapy for OUD
search includes more than one pharmaceutical for treatment of OUD

Exploring the Demographic and Professional Characteristics of Physicians and Nurse Practitioners Associated With Providing Medication-Assisted Treatment: A Retrospective Observational Study

Researchers used data from electronic license renewals in 2021 to examine what factors affect the likelihood of providing medication-assisted treatment (MAT) for opioid use disorder.  Physicians and nurse practitioners who were younger, practiced in a public or community health center, and offered a sliding fee scale in their practice had a greater likelihood of providing MAT. 
Posted Date

Center for Financing Reform & Innovation (CFRI)

The Center for Financing Reform and Innovation (CFRI) is a SAMHSA contract that seeks to understand financing mechanisms of behavioral health care to identify opportunities, innovations, and challenges to service delivery and access. Learn about behavioral health financing mechanisms, options, and innovations through CFRI reports and webinars using the CFRI website.  
Posted Date

Treating Opioid Use Disorder in General Practice — Diagnosis, Harm Reduction, and Medications

The New England Journal of Medicine reviews how primary care providers can best care for patients with opioid use disorder in their video. They guide clinicians on how to diagnose the disorder, build trust with patients, offer counseling on harm reduction, and use medications to treat addiction and withdrawal symptoms. They also emphasize the importance of reducing stigma to improve therapeutic alliances with this patient population.

Posted Date

Has the Treatment Gap for Opioid Use Disorder Narrowed in the U.S.?: A Yearly Assessment From 2010 to 2019

The United States overdose crisis continues unabated. Despite efforts to increase capacity for treating opioid use disorder (OUD) in the U.S., how actual treatment receipt compares to need remains unclear. In this cross-sectional study, progress is estimated in addressing the gap between OUD prevalence and OUD treatment receipt at the national and state levels from 2010 to 2019.
Posted Date

Bridging the Gap: A Practitioner’s Guide to Harm Reduction in Drug Courts

Innovative at their inception three decades ago, drug courts confront a practical and ethical obligation to reimagine some core practices and assumptions. A shifting legal and public health landscape means, for example, increased scrutiny of the courts’ focus on abstinence and mandated treatment, and the use of jail. This publication argues the most effective way for drug courts to evolve is by integrating the practices and principles of harm reduction
Posted Date